CALLICUTT JACK W sold GALT
November 18, 2025 · Form 4 insider transaction
CALLICUTT JACK W sold 28,120 shares of Galectin Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
28,120
Price
$0.00
Total value
N/A
InsiderCALLICUTT JACK W
RoleOfficer
SecurityStock option (right to buy)
Transaction codeM: Option exercise
Transaction dateNovember 18, 2025
Filing dateNovember 19, 2025
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.; The options vested as follows: 25% on each of June 30, 2022, December 31, 2022, June 30, 2023, and December 31, 2023.